Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])

RATIONALE: Umbilical cord–derived mesenchymal stem cells (UC-MSC) are easily accessible and expanded in vitro, possess distinct properties, and improve myocardial remodeling and function in experimental models of cardiovascular disease. Although bone marrow–derived mesenchymal stem cells have been p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartolucci, Jorge, Verdugo, Fernando J., González, Paz L., Larrea, Ricardo E., Abarzua, Ema, Goset, Carlos, Rojo, Pamela, Palma, Ivan, Lamich, Ruben, Pedreros, Pablo A., Valdivia, Gloria, Lopez, Valentina M., Nazzal, Carolina, Alcayaga-Miranda, Francisca, Cuenca, Jimena, Brobeck, Matthew J., Patel, Amit N., Figueroa, Fernando E., Khoury, Maroun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Clinical Track
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372053/
https://www.ncbi.nlm.nih.gov/pubmed/28974553
http://dx.doi.org/10.1161/CIRCRESAHA.117.310712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372053/
https://www.ncbi.nlm.nih.gov/pubmed/28974553
http://dx.doi.org/10.1161/CIRCRESAHA.117.310712

Ejemplares similares